関連レポート

　体外診断分析装置：世界市場2026年予測

サイト内検索

お探しの資料等をキーワード検索できます。英語検索も有効です。

出版元：BCC Research　 出版元について

発行年：2022年7月

定価 Single User License(1名様ライセンス)US$5,500 (米国ドル) /2 to 5 Users License(5名様)$6,600 /Site License $7,920 / Enterprise License $9,504

ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。

ご請求は円換算（お見積り日TTSレート）となります。

納品形態：PDF by Email

当調査レポートは英文　193ページになります。

商品コード：BCC420

【レポート紹介】

生殖医療技術の世界市場規模は2027年に240億ドルにまで増加する見通しです。2022年の同市場規模は171億ドルとみられ、2022年から2027年にかけて平均年成長率7.0％の漸増で推移するとレポートは分析しています。
当レポートでは、生殖医療技術の市場/技術的背景、各種セグメント別市場分析、COVID-19の影響、特許分析、主要企業プロフィールなどを盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】

◆イントロダクション

・調査目的
・調査対象
・調査手法

◆サマリーと調査ハイライト

◆市場概要

・生殖システムの構造及び機能
・リプロダクティブヘルスの課題及び傾向

◆不妊症市場

・イントロダクション及び不妊症の概要

◆COVID-19の影響

・医療機器/製薬業界への影響
・医療機器/医薬品分野への影響

◆治療方法

・不妊治療薬市場
※市場予測データ-2027年

◆生殖補助技術

・イントロダクション
・タイプ
・生殖補助技術市場
※市場予測データ-2027年

◆不妊症診断

・イントロダクション
・タイプ
・不妊症診断市場
※市場予測データ-2027年掲載

◆避妊市場

・イントロダクション及び避妊の概要
・医薬品
・避妊薬市場、製品タイプ別
・避妊器具市場、製品タイプ別
※市場予測データ-2027年掲載

◆性機能障害市場、市場予測-2027年

・イントロダクション及び概要
・性機能障害のタイプ
・性機能障害の原因
・性機能障害のデモグラフィック
・医薬品
・性機能障害の今後の進展
・市場全体の収益/予測
・性機能障害--医薬品市場、製品タイプ別
・性機能障害--機器市場、製品タイプ別
※市場予測データ掲載-2027年

◆特許

・特許分析、製造者別
・特許、企業別
・特許、用途別
・避妊
・性機能障害
・主要企業

◆グローバル、および主要地域別市場予測-2027年

・生殖医療技術の世界市場全体
・地域別市場(北米、欧州、アジア太平洋、その他地域)
・業界プレイヤー、カテゴリー別
・グローバル市場規模、製品タイプ別
※地域別の市場予測データ掲載-2027年
※地域別に主要国別の市場予測データ掲載（-2027年）

◆競合状況

・競合分析

◆生殖医療技術の主要企業プロフィール

・ACTAVIS, INC.
・BAYER AG
・BRISTOL-MYERS SQUIBB CO.
・CHURCH & DWIGHT COMPANY INC.
・COOPERSURGICAL INC.
・ELI LILLY & CO.
・EMD SERONO, INC.
・FERRING PHARMACEUTICALS
・GLAXOSMITHKLINE PLC
・JANSSEN PHARMACEUTICAL
・MERCK INC.
・NOVARTIS INTERNATIONAL AG
・PFIZER INC.
・PRINCETON BIOMEDITECH CORP.
・QUIDEL CORP.
・TEVA PHARMACEUTICALS.
・VIVUS INC.

（全193頁）

【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

Table of Contents (英文詳細目次）

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
What's New in This Update?
Scope of Report
Methodology
Information Source
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Introduction

Chapter 3 Industry Overview

Structure and Function of the Reproductive System

• Male
• Female
• Neuroendocrine Regulation
• Menarche
• Menstruation Cycle
• Phases of Sexual Responses
• Male Sexual Response
• Female Sexual Response
• Neurohormonal Control of the Female and Male Reproductive System
• Effects of Aging

Issues and Trends of Reproductive Health

• Contraceptive Insurance
• Over-the-Counter Birth Control Pills
• Pre-Implantation Genetic Diagnosis
• Designer Babies
• New Use for Contraceptives
• Aging and Infertility
• Death by Contraceptive Patch
• Sexual Dysfunction and Cancer
• Infertility and Cancer
• Signaling Pathway for Fertility Treatment
• Marketing Tactics
• Male Birth Control
• Merchandising Targeting Women
• Counterfeit Products
• Surplus Embryos and Fetuses
• Stem Cell and Other Controversial Issues — Selected International Views
• Controversial Disposal of Embryos
• Demographics

Chapter 4 Infertility Market

Introduction and Overview of Infertility

• Definition of Infertility
• Etiology of Infertility
• Evaluation of Fertility
• Unexplained Infertility
• Multiple Births
• Asia Factor

Chapter 5 COVID-19 Impact

Introduction
COVID-19: Impact on the Medical Devices and Pharma Industries

• Decline/Delay in Elective Procedures
• COVID-19 Impact on Supply Chain
• U.S. Supply Chain: COVID-19 Impact
• European Supply Chain: COVID-19 Impact
• APAC Supply Chain: COVID-19 Impact
• China: COVID-19 Impact

COVID-19 Impact on Medical Device and Pharmaceutical Product Segments

• COVID-19 Impact on Critical Devices
• COVID-19 Impact on Human Reproductive Technologies and Products Markets

Chapter 6 Methods of Treatment

Fertility Pharmaceuticals

• Introduction and Types
• Market Revenues and Forecast
• Future Advancements in Infertility Products
• Competitive Analysis

Chapter 7 Assistive Reproductive Technologies

Introduction
Types

• IVF
• Ovulation Induction
• Oocyte Retrieval
• Intracytoplasmic Sperm Injection (ICSI)
• Fertilization
• Embryo Transfer
• Results of IVF
• GIFT
• ZIFT
• Wombs for Rent
• Oocyte Donation
• Frozen Embryos
• United States Fertility Clinics
• Market Revenues and Forecast
• Future Trends in Assistive Reproductive Technology
• Competitive Analysis

Chapter 8 Fertility Diagnostics

Introduction
Types

• Urine Studies
• Market Revenues and Forecast
• Competitive Analysis
• Future Advancements in Diagnostic Fertility Treatment
• Total Infertility Market Revenues and Forecast

Chapter 9 Contraception Market

Introduction and Overview of Contraception
Pharmaceuticals

• Types
• Other Drug Regimens for Contraception
• Market Revenues and Forecast
• Competitive Analysis
• Prescription Devices
• Market Revenues and Forecast
• Competitive Analysis
• Future Advancements in Contraception

Total Market Revenues and Forecast

Chapter 10 Sexual Dysfunction Market

Introduction and Overview
Types of Sexual Dysfunction
Causes of Sexual Dysfunction
Demographics of Sexual Dysfunction
Pharmaceuticals
Introduction and Types
Market Revenues and Forecast

• Competitive Analysis
• Devices

Market Revenues and Forecast
Future Advancements in Sexual Dysfunction
Total Market Revenues and Forecast

Chapter 11 Patents

Patent Analysis by Manufacturer
Patent by Company
Patents by Application

• Infertility Treatments

Contraception
Sexual Dysfunction
Leading Market Manufacturers

Chapter 12 Total Market

Total Global Market for Reproductive Technologies and Products, by Region

• North America
• Europe
• Asia-Pacific
• Rest of the World

Total Market Size by Category
Industry Participants by Category
Total Market Size by Product Type

Chapter 13 Competitive Landscape

Competitive Analysis

Chapter 14 Company Profiles

ACTAVIS, INC.
BAYER AG
BRISTOL-MYERS SQUIBB CO.
CHURCH & DWIGHT COMPANY INC.
COOPERSURGICAL INC.
ELI LILLY & CO.
EMD SERONO, INC.
FERRING PHARMACEUTICALS
GLAXOSMITHKLINE PLC
JANSSEN PHARMACEUTICAL
MERCK INC.
NOVARTIS INTERNATIONAL AG
PFIZER INC.
PRINCETON BIOMEDITECH CORP.
QUIDEL CORP.
TEVA PHARMACEUTICALS.
VIVUS INC.
Selected List of U.S. Fertility Clinics
List of Companies

Chapter 15 Appendix: Acronyms

List of Tables

Summary Table : Global Market for Human Reproductive Technologies and Products, by Product Type, Through 2027
Table 1 : Structural Homologues of the Male and Female Reproductive Systems
Table 2 : U.S. Live Birth Rates, 2000-2020
Table 3 : U.S. Population, by Selected Age Groups, and by Percent of Total Population, 2010-2030
Table 4 : Characteristics of Women Who Have Had a Child in the Last Year, 2008 and 2010
Table 5 : Women Who Have Had a Child in the Last Year, by Age and Labor FORCE Status, 1980-2008
Table 6 : Contraceptive Use Share, by Type, by Age, Ethnic Group and Marital Status
Table 7 : Birth Rate in Europe, by Country and Year, 1960-2020
Table 8 : Selected Prescription Fertility Drugs
Table 9 : Global Infertility Pharmaceuticals Market, Through 2027
Table 10 : Infertility Drugs in Development
Table 11 : Global Infertility Pharmaceutical Manufacturer Market, 2021
Table 12 : National Summary of Assistive Reproductive Therapies in U.S., 2020
Table 13 : National Assistive Reproductive Therapies Cycle Profile, 2019
Table 14 : Pregnancy Success Rates, 2019
Table 15 : Number of IVF Clinics/Centers by Selected Countries
Table 16 : Global Assistive Reproductive Technologies Market, Through 2027
Table 17 : Global Infertility Assistive Reproductive Products Manufacturer Market, 2021
Table 18 : Global Fertility Diagnostics Market, by Product Type, Through 2027
Table 19 : Global Fertility Diagnostic Manufacturer Market, 2021
Table 20 : Global Infertility Treatments Market, by Product Type, Through 2027
Table 21 : Contraceptive Status and Use Rates, U.S. Women Aged 15-49, 2015-2017
Table 22 : Contraceptive Use, by Region, 2015 and 2030
Table 23 : Most Commonly Used Oral and Transdermal Contraceptives
Table 24 : Estrogen and Progestin Hormone Doses in Combined Birth Control Pills
Table 25 : Potency of Different Oral Contraceptive Progestins
Table 26 : Current Pill Problems and Choice of Pill to Switch To
Table 27 : Global Contraceptive Pharmaceuticals Market, by Product Type, Through 2027
Table 28 : Global Contraceptive Pharmaceutical Manufacturer Market, 2021
Table 29 : Selected Contraceptive Device Treatments, 2021
Table 30 : Global Contraceptive Devices Market, by Product Type, Through 2027
Table 31 : Global Contraceptive Device Manufacturer Market, 2021
Table 32 : Contraceptives in Development
Table 33 : Global Contraceptive Products Market, by Product Type, Through 2027
Table 34 : Selected Sexual Dysfunction Pharmaceutical Treatments
Table 35 : Global Sexual Dysfunction Pharmaceuticals Market, by Product Type, Through 2027
Table 36 : Global Sexual Dysfunction Pharmaceuticals Manufacturer Market, 2021
Table 37 : Selected Sexual Dysfunction Device Treatments
Table 38 : Global Sexual Dysfunction Devices Market, by Product Type, Through 2027
Table 39 : Global Sexual Dysfunction Devices Manufacturer Market, 2021
Table 40 : Sexual Dysfunction Drugs in Development
Table 41 : Global Sexual Dysfunction Treatments Market, by Product Type, Through 2027
Table 42 : Selected Manufacturer Patents for Reproductive Products and Related Technology, by Application, 2015-Present
Table 43 : Selected Manufacturer Patents for Reproductive Products and Related Technology, by Application, 1976-Present
Table 44 : Patent Analysis, by Selected Leading Reproductive Treatment Manufacturer, 1976-Present
Table 45 : Global Reproductive Technologies and Products Market, Through 2027
Table 46 : Global Reproductive Technologies and Products Market, by Region, Through 2027
Table 47 : North American Reproductive Technologies and Products Market, by Country, Through 2027
Table 48 : European Reproductive Technologies and Products Market, by Country, Through 2027
Table 49 : Asia-Pacific Reproductive Technologies and Products Market, by Country, Through 2027
Table 50 : RoW Reproductive Technologies and Products Market, Through 2027
Table 51 : Global Reproductive Technologies and Products Market, by Region, 2021
Table 52 : Global Reproductive Technologies and Products Market, by Region, 2027
Table 53 : Global Reproductive Technologies and Products Market, by Product Type, Through 2027
Table 54 : Global Reproductive Technologies and Products Market, 2019
Table 55 : Reproductive Industry Participants, by Product Category
Table 56 : Global Reproductive Technologies and Products Market, by Product Type, Through 2017
Table 57 : List of Companies
Table 58 : Acronyms Used in This Report"

List of Figures

Summary Figure A : Global Market for Human Reproductive Technologies and Products, by Product Type, 2019-2027
Summary Figure B : Global Market Share of Human Reproductive Technologies and Products, by Product Type, 2021
Figure 1 : U.S. Live Birth Rates, 2000-2020
Figure 2 : U.S. Population Selected Age Groups, by Percent of Total Population, 2010-2030
Figure 3 : Global Infertility Pharmaceutical Manufacturer Market Share, 2021
Figure 4 : Global Infertility Assistive Reproductive Products Manufacturer Market Share, 2021
Figure 5 : Global Fertility Diagnostic Manufacturer Market Share, 2021
Figure 6 : Global Infertility Treatments Market, by Product Type, 2019-2027
Figure 7 : Global Contraceptive Pharmaceuticals Manufacturer Market Share, 2021
Figure 8 : Global Contraceptive Device Manufacturer Market Share, 2021
Figure 9 : Global Contraceptive Products Market, by Product Type, 2019-2027
Figure 10 : Global Sexual Dysfunction Pharmaceuticals Manufacturer Market Share, 2021
Figure 11 : Global Sexual Dysfunction Devices Manufacturer Market Share, 2021
Figure 12 : Global Sexual Dysfunction Treatments Market, by Product Type , 2019-2027
Figure 13 : Global Reproductive Technologies and Products Market Share, by Region, 2021
Figure 14 : Global Reproductive Technologies and Products Market Share, by Region, 2027
Figure 15 : Global Reproductive Technologies and Products Market, by Product Type, 2019-2027
Figure 16 : Number of Selected Manufacturers, by Segment, 2019
Figure 17 : Global Reproductive Technologies and Products Market Share, 2019
Figure 18 : Global Reproductive Technologies and Products Market, by Product Type, 2019-2027